Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta Sells 15,160 Shares

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 15,160 shares of the business’s stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $3.92, for a total value of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares of the company’s stock, valued at $844,736.48. This trade represents a 6.57 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Amit Gupta also recently made the following trade(s):

  • On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The stock was sold at an average price of $3.67, for a total value of $21,887.88.

Cardlytics Trading Up 1.3 %

NASDAQ:CDLX opened at $3.88 on Friday. The firm has a 50-day simple moving average of $3.66 and a 200-day simple moving average of $4.39. Cardlytics, Inc. has a one year low of $2.76 and a one year high of $20.52. The firm has a market cap of $197.18 million, a P/E ratio of -0.64 and a beta of 1.53. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18.

Cardlytics (NASDAQ:CDLXGet Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.18. The company had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. Cardlytics’s revenue was down 15.1% compared to the same quarter last year. During the same period last year, the company posted ($0.26) earnings per share. Equities analysts anticipate that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CDLX has been the topic of a number of recent analyst reports. Evercore ISI initiated coverage on Cardlytics in a research note on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price on the stock. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. Finally, Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $6.92.

Get Our Latest Stock Report on Cardlytics

Hedge Funds Weigh In On Cardlytics

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Tallon Kerry Patrick purchased a new stake in shares of Cardlytics during the fourth quarter valued at about $37,000. Atom Investors LP bought a new position in shares of Cardlytics during the 3rd quarter worth approximately $33,000. XTX Topco Ltd purchased a new stake in Cardlytics during the second quarter valued at approximately $107,000. SG Americas Securities LLC acquired a new stake in Cardlytics in the third quarter valued at approximately $45,000. Finally, Intech Investment Management LLC purchased a new position in Cardlytics in the third quarter worth $47,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.